Tilray, Inc.

TLRY Details

Tilray, Inc. (NASDAQ: TLRY) is a significant cannabis lifestyle and consumer packaged goods company operating in Canada, the United States, Europe, Australia, and Latin America. Its headquarters are in Leamington and New York. The majority of its revenue comes from Canada and the worldwide medicinal cannabis export industry. CBD products from Manitoba Harvest and beer from SweetWater are the only items available in the United States.

Latest News:

• Inorganic Endeavors: TLRY announced the strategic acquisition of Breckenridge Distillery, a leading distilled spirits platform in Breckenridge, Colorado, on December 08, 2021. The transaction is expected to be immediately accretive to TLRY's EBITDA. Breckenridge and TLRY's existing SweetWater brands have many potentials to complement one other, boosting their respective reach and creating more lucrative growth in the beverage alcohol category, according to TLRY.
• Launch of Oral Strips: TLRY stated on December 2, 2021, that Aphria, its medical subsidiary, has introduced medicinal cannabis oral strips in THC and CBD-rich variations. Each Aphria medical strip comprises a thin, edible film containing rapidly dissolving, micronized cannabinoids entering the bloodstream, giving patients a fast-acting and precise dosing experience for various disorders.

Q1FY22 Results:

• Growth in Topline: TLRY reported a 43.01% increase in net revenues to USD 168.02 million in Q1FY22 (ended August 31, 2021) from USD 117.49 million in Q1FY21 due to the rise in sales from the cannabis business and the beginning of new beverage and wellness business revenues.
• Surge in Losses: TLRY witnessed an increase in net losses to USD 34.60 million in Q1FY22 from USD 21.74 million in Q1FY21.
• Cash & Debt Position: The company's cash and cash equivalents were USD 376.30 million as of August 31, 2021, with total debt (including convertible debentures) of USD 816.60 million.

Key Risks:

• Customer Concentration Risk: A significant amount of TLRY's revenue comes from major clients. Its revenue could drop dramatically if it fails to retain or increase its client connections or if key consumers lower their purchases.
• Dependence on Third Parties: TLRY relies heavily on producing and selling approved and certified cannabis flowers. It may need to rely on third-party suppliers for high-grade cannabis flowers, which might raise expenses and expose the company to unstable supply chains and product quality.

Valuation Methodology: EV/Sales Multiple Based Relative Valuation

(Analysis by Kalkine Group)

* % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.

TLRY Daily Technical Chart (Source: REFINITIV)

Stock Recommendation:

TLRY's share price has fallen 69.25% in the past nine months and made a new 52 week low today. The stock is currently trading below its 50 and 200 DMA levels, and its RSI Index is at 27.57, indicating an oversold zone. We have valued the stock using the EV/Sales-based relative valuation methodology and arrived at a target price of USD 9.00.

Considering the significant correction in the stock price in the past nine months, recent acquisitions, new product launches, current valuation, and associated risks, we recommend a "Speculative Buy" rating on the stock at the current price of USD 7.34, down 8.02% as of December 20, 2021, 1:29 PM ET.

* The reference data in this report has been partly sourced from REFINITIV.

* All forecasted figures and industry information have been taken from REFINITIV.

*Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached.

Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.